A detailed history of Bluestein R H & CO LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bluestein R H & CO LLC holds 3,415 shares of GILD stock, worth $300,793. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,415
Previous 4,115 17.01%
Holding current value
$300,793
Previous $254,000 16.93%
% of portfolio
0.01%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $41,678 - $47,607
-700 Reduced 17.01%
3,415 $211,000
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $47,383 - $51,121
700 Added 20.5%
4,115 $287,000
Q1 2021

May 12, 2021

SELL
$60.0 - $68.46 $18,300 - $20,880
-305 Reduced 8.2%
3,415 $221,000
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $165,191 - $188,227
-2,916 Reduced 43.94%
3,720 $217,000
Q3 2020

Nov 12, 2020

SELL
$62.1 - $78.08 $10.4 Million - $13.1 Million
-167,164 Reduced 96.18%
6,636 $419,000
Q2 2020

Aug 12, 2020

BUY
$72.34 - $84.0 $12.2 Million - $14.2 Million
169,081 Added 3582.98%
173,800 $13.4 Million
Q1 2020

May 12, 2020

BUY
$62.63 - $80.22 $295,550 - $378,558
4,719 New
4,719 $353,000
Q4 2018

Feb 13, 2019

SELL
$60.54 - $79.0 $161,278 - $210,456
-2,664 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $189,889 - $210,242
2,664 New
2,664 $206,000
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $182,428 - $214,145
-2,564 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $184,890 - $219,145
2,564
2,564 $208,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bluestein R H & CO LLC Portfolio

Follow Bluestein R H & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.